- Home
- BLMN vs BCRX Comparison
BLMN vs BCRX Comparison
Compare BLMN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMN
- BCRX
- Stock Information
- Founded
- BLMN 1988
- BCRX 1986
- Country
- BLMN United States
- BCRX United States
- Employees
- BLMN N/A
- BCRX N/A
- Industry
- BLMN Restaurants
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLMN Consumer Discretionary
- BCRX Health Care
- Exchange
- BLMN Nasdaq
- BCRX Nasdaq
- Market Cap
- BLMN 1.4B
- BCRX 1.5B
- IPO Year
- BLMN 2012
- BCRX 1994
- Fundamental
- Price
- BLMN $12.11
- BCRX $7.61
- Analyst Decision
- BLMN Hold
- BCRX Buy
- Analyst Count
- BLMN 11
- BCRX 6
- Target Price
- BLMN $16.90
- BCRX $15.17
- AVG Volume (30 Days)
- BLMN 1.8M
- BCRX 2.2M
- Earning Date
- BLMN 02-21-2025
- BCRX 02-24-2025
- Dividend Yield
- BLMN 7.95%
- BCRX N/A
- EPS Growth
- BLMN N/A
- BCRX N/A
- EPS
- BLMN N/A
- BCRX N/A
- Revenue
- BLMN $4,547,161,000.00
- BCRX $412,579,000.00
- Revenue This Year
- BLMN N/A
- BCRX $38.44
- Revenue Next Year
- BLMN N/A
- BCRX $21.23
- P/E Ratio
- BLMN N/A
- BCRX N/A
- Revenue Growth
- BLMN N/A
- BCRX 29.92
- 52 Week Low
- BLMN $11.03
- BCRX $4.03
- 52 Week High
- BLMN $30.13
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- BLMN 49.52
- BCRX 50.40
- Support Level
- BLMN $11.15
- BCRX $6.96
- Resistance Level
- BLMN $11.99
- BCRX $8.02
- Average True Range (ATR)
- BLMN 0.55
- BCRX 0.45
- MACD
- BLMN 0.06
- BCRX -0.04
- Stochastic Oscillator
- BLMN 60.00
- BCRX 42.48
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.